BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16982832)

  • 1. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells.
    Shoaf K; Mulvey GL; Armstrong GD; Hutkins RW
    Infect Immun; 2006 Dec; 74(12):6920-8. PubMed ID: 16982832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.
    Kittana H; Quintero-Villegas MI; Bindels LB; Gomes-Neto JC; Schmaltz RJ; Segura Munoz RR; Cody LA; Moxley RA; Hostetter J; Hutkins RW; Ramer-Tait AE
    Microbiology (Reading); 2018 Feb; 164(2):154-162. PubMed ID: 29256851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis for N-acetyllactosamine-mediated inhibition of enteropathogenic Escherichia coli localized adherence.
    Hyland RM; Griener TP; Mulvey GL; Kitov PI; Srivastava OP; Marcato P; Armstrong GD
    J Med Microbiol; 2006 Jun; 55(Pt 6):669-675. PubMed ID: 16687583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the virulence factor, BfpA, by enteropathogenic Escherichia coli is essential for apoptosis signalling but not for NF-kappaB activation in host cells.
    Melo AR; Lasunskaia EB; de Almeida CM; Schriefer A; Kipnis TL; Dias da Silva W
    Scand J Immunol; 2005 Jun; 61(6):511-9. PubMed ID: 15963045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific cell adhesion of enteropathogenic Escherichia coli is mediated by type IV bundle-forming pili.
    Tobe T; Sasakawa C
    Cell Microbiol; 2002 Jan; 4(1):29-42. PubMed ID: 11856171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of perA sequences and their correlation with autoaggregation in typical enteropathogenic Escherichia coli isolates collected in Japan and Thailand.
    Iida M; Okamura N; Yamazaki M; Yatsuyanagi J; Kurazono T; Suzuki R; Hiruta N; Isobe J; Seto K; Kawano K; Narimatsu H; Ratchtrachenchai OA; Okabe N; Ito K
    Microbiol Immunol; 2010 Apr; 54(4):184-95. PubMed ID: 20377747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasmid-encoded type IV fimbrial gene of enteropathogenic Escherichia coli associated with localized adherence.
    Donnenberg MS; Girón JA; Nataro JP; Kaper JB
    Mol Microbiol; 1992 Nov; 6(22):3427-37. PubMed ID: 1362446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence inhibition of enteropathogenic Escherichia coli by chitooligosaccharides with specific degrees of acetylation and polymerization.
    Quintero-Villegas MI; Aam BB; Rupnow J; Sørlie M; Eijsink VG; Hutkins RW
    J Agric Food Chem; 2013 Mar; 61(11):2748-54. PubMed ID: 23428168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants.
    Martinez MB; Taddei CR; Ruiz-Tagle A; Trabulsi LR; Girón JA
    J Infect Dis; 1999 Jan; 179(1):269-74. PubMed ID: 9841853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines.
    Weichert S; Jennewein S; Hüfner E; Weiss C; Borkowski J; Putze J; Schroten H
    Nutr Res; 2013 Oct; 33(10):831-8. PubMed ID: 24074741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides.
    Quintero M; Maldonado M; Perez-Munoz M; Jimenez R; Fangman T; Rupnow J; Wittke A; Russell M; Hutkins R
    Curr Microbiol; 2011 May; 62(5):1448-54. PubMed ID: 21293857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli.
    Saldaña Z; Erdem AL; Schüller S; Okeke IN; Lucas M; Sivananthan A; Phillips AD; Kaper JB; Puente JL; Girón JA
    J Bacteriol; 2009 Jun; 191(11):3451-61. PubMed ID: 19218393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteropathogenic Escherichia coli virulence factor bundle-forming pilus has a binding specificity for phosphatidylethanolamine.
    Khursigara C; Abul-Milh M; Lau B; Girón JA; Lingwood CA; Barnett Foster DE
    Infect Immun; 2001 Nov; 69(11):6573-9. PubMed ID: 11598024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bundle-forming pilus of enteropathogenic Escherichia coli in host cell adherence and in microcolony development.
    Tobe T; Sasakawa C
    Cell Microbiol; 2001 Sep; 3(9):579-85. PubMed ID: 11553010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition by nifurzide of the adhesion capacity of enteropathogenic colibacillus to HEP-2 cells].
    Darfeuille-Michaud A; Forestier C; Rich C; Wash E; Joly B; Cluzel R
    Pathol Biol (Paris); 1989 Dec; 37(10):1090-3. PubMed ID: 2691964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LamB-mediated adherence of enteropathogenic Escherichia coli to HEp-2 cells.
    Subramanian K; Shankar RB; Meenakshisundaram S; Lakshmi BS; Williams PH; Balakrishnan A
    J Appl Microbiol; 2008 Sep; 105(3):715-22. PubMed ID: 18397259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.
    Abul-Milh M; Wu Y; Lau B; Lingwood CA; Barnett Foster D
    Infect Immun; 2001 Dec; 69(12):7356-64. PubMed ID: 11705908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type IV bundle-forming pilus of enteropathogenic Escherichia coli undergoes dramatic alterations in structure associated with bacterial adherence, aggregation and dispersal.
    Knutton S; Shaw RK; Anantha RP; Donnenberg MS; Zorgani AA
    Mol Microbiol; 1999 Aug; 33(3):499-509. PubMed ID: 10417641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Egg yolk anti-BfpA antibodies as a tool for recognizing and identifying enteropathogenic Escherichia coli.
    de Almeida CM; Quintana-Flores VM; Medina-Acosta E; Schriefer A; Barral-Netto M; Dias da Silva W
    Scand J Immunol; 2003 Jun; 57(6):573-82. PubMed ID: 12791096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attaching and effacing Escherichia coli isolated from dogs in Brazil: characteristics and serotypic relationship to human enteropathogenic E. coli (EPEC).
    Nakazato G; Gyles C; Ziebell K; Keller R; Trabulsi LR; Gomes TA; Irino K; Da Silveira WD; Pestana De Castro AF
    Vet Microbiol; 2004 Aug; 101(4):269-77. PubMed ID: 15262000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.